861640-70-2

Upstream product

• 52927-23-8 5-bromo-1-naphthol 
• 162648-54-6 1-[((9H-fluoren-9-yl)methoxy)carbonylamino]cyclohexanecarboxylic acid 
• 861640-72-4 (1-{(S)-2-Carbamoyl-1-[(S)-2-(5-hydroxy-naphthalen-1-ylmethyl)-pent-4-enylcarbamoyl]-ethylcarbamoyl}-cyclohexyl)-carbamic acid 9H-fluoren-9-ylmethyl ester 
• 861640-68-8 (2S)-2-[[(1-aminocyclohexyl)carbonyl]amino]-N¹-[(2S)-2-(5-hydroxy-1-naphthalenylmethyl)-4-pentenyl]butanediamide 
• 861640-63-3 (4S)-3-[(2S)-2-(5-(2-(trimethylsilyl)ethyl)oxy-1-naphthalenylmethyl)-1-oxo-4-penten-1-yl]-4-phenyl-2-oxazolidinone 
• 861640-65-5 2-[(2S)-((5-(2-(trimethylsilyl)ethyl)oxy-1-naphthalenyl)methyl)-4-penten-1-yl]-1H-isoindole-1,3(2H)-dione 
• 861640-62-2 (4S)-3-[3-(5-(2-(trimethylsilyl)ethyl)oxy-1-naphthalenyl)-1-oxo-2-propan-1-yl]-4-phenyl-2-oxazolidinone 
• 861640-61-1 (4S)-3-[3-(5-(2-(trimethylsilyl)ethyl)oxy-1-naphthalenyl)-1-oxo-2-propen-1-yl]-4-phenyl-2-oxazolidinone 
• 861640-67-7 (2S)-2-amino-N¹-[(2S)-2-(5-hydroxy-1-naphthalenylmethyl)-4-penten-1-yl]butanediamide 
• 861640-60-0 (4S)-3-[3-(5-hydroxy-1-naphthalenyl)-1-oxo-2-propen-1-yl]-4-phenyl-2-oxazolidinone 
• 861640-66-6 (2S)-1-amino-2-(2-propen-1-yl)-3-(5-((2-(trimethylsilyl)ethyl)oxy)-1-naphthalenyl)propane 
• 861640-64-4 (2S)-(2-propen-1-yl)-3-(5-(2-(trimethylsilyl)ethyl)oxy-1-naphthalenyl)propan-1-ol 
• 861640-69-9 (βS,γS)-β-[[1-[[(1S)-3-amino-1-[[(2S)-2-(5-hydroxy-1-naphthalenylmethyl)-4-pentenyl]aminocarbonyl]-3-oxopropyl]aminocarbonyl]cyclohexyl]aminocarbonyl]-4-[4-[bis(tert-butoxy)phosphoryl]methyl]-γ-ethenylbenzenebutanoic acid 1,1-dimethylethyl ester 

Downstream Products

• 861640-71-3 C₆₇H₉₆N₇O₁₃PS 

Relevant academic research and scientific papers

Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity

Although considerable effort has been devoted to developing Grb2 SH2 domain-binding antagonists, important questions related to ligand specificity, and identification of intracellular targets remain unanswered. In order to begin addressing these issues, t